David Hallal brings his first cell therapy company into the fold, and it's tied to a major league financing deal

David Hallal wasn’t kidding around when he said that his startup ElevateBio was ready to do business.

The ex-Alexion CEO is unveiling his first portfolio deal for his $150 million cell and gene therapy startup ElevateBio this morning.